Skip to main content

Advertisement

Log in

The role of excitotoxicity in ALS – what is the evidence?

  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

It is well accepted that excitotoxic mechanisms contribute to the pathogenesis of acute neuronal death in stroke, epilepsy, or brain trauma. It is less widely acknowledged that excitotoxic mechanisms play a role in the pathogenesis of chronic neurological disorders, in particular neurodegenerative diseases. However, evidence is accumulating that this mechanism is indeed part of the pathogenesis of late-onset neurodegenerative diseases. One of the clinical examples may be amyotrophic lateral sclerosis, a disease in which antiexcitotoxic strategies have neuroprotective effects in both, an established animal model and in man. In addition, there is accumulating neuropathological, pathobiochemical and pathophysiological evidence which indicates that excitotoxic mechanisms are part of the pathogenesis of the human disease and consequently part of the mechanisms explaining selective vulnerability (“pathoclisis”) in the human motor system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ludolph, A., Meyer, T. & Riepe, M. The role of excitotoxicity in ALS – what is the evidence?. J Neurol 247 (Suppl 1), I7–I16 (2000). https://doi.org/10.1007/s004150050552

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004150050552

Navigation